Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 473 of 5804
-
AI boosts kidney drug dosing: hope for membranous nephropathy patients
Disease control Recruiting nowMembranous nephropathy is an autoimmune disease affecting the kidney, and the most common cause of nephrotic syndrome in non-diabetic Caucasian adults. The course of this disease is highly variable from one individual to another, ranging from spontaneous remission to progressive …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Heart attack survivors: could a dual ablation approach stop deadly rhythms?
Disease control Recruiting nowThe EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2…
Phase: NA • Sponsor: MEDICOVER SP Z O.O. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Waterjet vs. scalpel: new trial tests gentler prostate cancer treatment
Disease control OngoingThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will…
Phase: NA • Sponsor: PROCEPT BioRobotics • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New shot could tame thyroid eye disease
Disease control OngoingThis is a clinical trial assessing the safety and tolerability of an investigational drug, VRDN-003, in participants with Thyroid Eye Disease (TED).
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New daily pill could stop debilitating swelling attacks in HAE patients
Disease control Recruiting nowThis is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angioedema attacks in participants aged ≥12 years with Hereditary Angioedema
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Glow-in-the-Dark dye could spare breast cancer patients unnecessary surgery
Diagnosis Recruiting nowBreast malignant tumors are a serious threat to women's health, and the current treatment for breast malignant tumors is still dominated by surgery, but the problems faced by patients after surgery such as edema and tumor recurrence are still relatively common, and the high recur…
Sponsor: Yunnan Cancer Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 13:26 UTC
-
Real-world data on two-drug combo for hard-to-treat hodgkin lymphoma
Disease control CompletedApproximately 20% of patients diagnosed with Hodgkin lymphoma will eventually experience progression or relapse after first-line treatment, which carries a significant risk of disease-related death. Although several pilot studies have demonstrated high rates of sustained response…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Heart shield? diabetes drug tested to prevent chemo heart damage
Prevention Recruiting nowThe goal of this randomized, double-blind, placebo-controlled clinical trial is to determine whether dapagliflozin, a sodium-glucose cotransporter-2 (SGLT-2) inhibitor, can help prevent anthracycline-induced cardiotoxicity caused by anthracycline chemotherapy in adult women with …
Phase: PHASE2 • Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Nipple-saving breast surgery under the microscope: is it safe for gene carriers?
Knowledge-focused Recruiting nowPatients with a germline pathogenic variant (GPV) in high-penetrance breast cancer susceptibility genes who are considering risk reducing mastectomy (RRM) often strongly desire to keep their nipple areola complex but inquire as to whether it is safe to do so. Relative to traditio…
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New hope for breast cancer spread to liver: targeted chemo trial opens
Disease control Recruiting nowStudy Objective: To Evaluate the Efficacy of Albumin-Bound Paclitaxel Combined with Nedaplatin via Hepatic Arterial Infusion as Later-Line Therapy for Breast Cancer Patients with Liver Metastases After Failure of Standard Treatment. Outcome Measures:Primary Outcome: Liver Progre…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New HIV strategy aims to curb epidemic among nigerian teens
Disease control Recruiting nowTwo combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New triple therapy could extend life for esophageal cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous cell cancer in adults.
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Mail-Order heart screening could save thousands – but does it work?
Prevention Recruiting nowU-SCREEN is a randomized controlled trial evaluating whether systematic home-based multimodal screening for cardiovascular risk conditions, offered to residents in Region Uppsala turning 50, 55, 60, 65, 70 or 75 years of age, can identify clinically actionable cardiovascular risk…
Phase: NA • Sponsor: Johan Sundström • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Spinal injury drug combo shows promise for restoring leg function
Disease control Recruiting nowThe purpose of this study is to test a strategy to potentiate functional recovery of lower limb motor function in individuals with spinal cord injury (SCI). The FDA approved drug, Dalfampridine (4-AP). 4-AP will be used twice-daily in combination of Spike-timing-dependent plastic…
Phase: PHASE1, PHASE2 • Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for young brain cancer patients: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThe goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric and young adult patients with a high-grade glioma (HGG) harboring an IDH1 mutation. The main question the study aims to answer is whether the combination of olut…
Phase: PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Brain zaps timed to your own waves may boost memory in Alzheimer's
Disease control Recruiting nowThe project is a placebo-controlled study that aims to use closed-loop transcranial alternating current stimulation (tACS) to study patients with symptoms of mild cognitive impairment which is likely due to Alzheimer's disease or another form of dementia (AD-MCI). Patients will u…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New pill could ease painful skin condition
Disease control OngoingThe purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New dengue vaccine shows promise in japan trial
⭐️ VACCINE ⭐️ CompletedDengue fever is caused by an infection with the dengue virus. Vaccination with TDV can help prevent dengue fever. The main purpose of this study is to learn about TDV's ability to create an immune response in adults, adolescents, and children administered. In this study, partici…
Phase: PHASE2, PHASE3 • Sponsor: Takeda • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:07 UTC
-
Massive stroke trial aims to Fine-Tune clot removal for better recovery
Disease control Recruiting nowSTEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug combo aims to tame hepatitis b virus
Disease control Recruiting nowBackground: Chronic hepatitis B virus (HBV) infection affects 292 million people worldwide; 887,000 die each year from cirrhosis, liver cancer, and related issues. Treatment options are limited. Objective: To test 2 drugs (VIR-2218 and peginterferon) in people with mild or ina…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC